Growth Metrics

Tarsus Pharmaceuticals (TARS) Preferred Stock Liabilities (2020)

Tarsus Pharmaceuticals has reported Preferred Stock Liabilities over the past 1 years, most recently at $103.2 million for Q3 2020.